Your browser doesn't support javascript.
loading
Development of latent Interferon alpha 2b as a safe therapeutic for treatment of Hepatitis C virus infection.
Gull, Iram; Aslam, Muhammad Shahbaz; Tipu, Imran; Mushtaq, Roohi; Ali, Tehseen Zamir; Athar, Muhammad Amin.
Afiliación
  • Gull I; Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus, University of the Punjab, Lahore, 54590, Pakistan. iram.ibb@pu.edu.pk.
  • Aslam MS; Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus, University of the Punjab, Lahore, 54590, Pakistan.
  • Tipu I; Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus, University of the Punjab, Lahore, 54590, Pakistan.
  • Mushtaq R; Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus, University of the Punjab, Lahore, 54590, Pakistan.
  • Ali TZ; Punjab University Health Centre, Quaid-i-Azam Campus, University of the Punjab, Lahore, 54590, Pakistan.
  • Athar MA; Institute of Biochemistry and Biotechnology, Quaid-i-Azam Campus, University of the Punjab, Lahore, 54590, Pakistan.
Sci Rep ; 9(1): 10867, 2019 07 26.
Article en En | MEDLINE | ID: mdl-31350425
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Diseño de Fármacos / Hepacivirus / Hepatitis C Crónica / Interferón alfa-2 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Pakistán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Diseño de Fármacos / Hepacivirus / Hepatitis C Crónica / Interferón alfa-2 Tipo de estudio: Prognostic_studies Límite: Female / Humans / Male Idioma: En Revista: Sci Rep Año: 2019 Tipo del documento: Article País de afiliación: Pakistán